Viewing Study NCT02869633


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-03-06 @ 12:07 PM
Study NCT ID: NCT02869633
Status: COMPLETED
Last Update Posted: 2023-10-23
First Post: 2016-08-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
Sponsor:
Organization: